Qdenga Vaccine
Please note, at the moment, the JCVI has recommended that the following groups could be offered the Qdenga® vaccine:
Individuals aged 4 years of age and older who have had dengue infection in the past and who are:
• Planning to travel to areas where there is a risk of dengue infection or areas with an ongoing outbreak of dengue.
or
• Exposed to dengue virus through their work, for example, laboratory staff working with the virus.
However, it is not a contraindication (under EMC SPC) to administer Qdenga to individuals who have not had a dengue infection in the past. Nevertheless, based on the above statement, it is highly recommended to conduct a risk-benefit evaluation. Clinicians should exercise their professional judgment to determine the suitability of administering Qdenga in the absence of a prior dengue infection.
